GlassScriptPhysician profile
Deena H Theiss
NPI 1962589887
$5,456.36
in general payments reported to CMS, 2019-2025
26 companies · $360 in 2025
The $360 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $449 · 2020: $385 · 2021: $568 · 2022: $581 · 2023: $2,850 · 2024: $264 · 2025: $360.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,902 · Food and Beverage: $1,572.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,901.61 |
| Food and Beverage | $1,572.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $3,322.52 | 2019-2025 | Solyx Sis System, Capio Rp, Rezum Generator |
| Procept Biorobotics Corporation | $478.85 | 2023-2025 | Aquabeam System, Aquabeam Robotic System |
| Astellas Pharma US INC | $378.86 | 2019-2022 | |
| Srs Medical Systems, INC. | $174.84 | 2021 | |
| Teleflex LLC | $163.19 | 2023 | Urolift |
| Olympus America INC. | $158.76 | 2022-2025 | Soltive |
| Dendreon Pharmaceuticals LLC | $144.63 | 2019 | |
| Photocure INC | $97.52 | 2019 | |
| Endo Pharmaceuticals INC. | $79.67 | 2020-2024 | Xiaflex, Aveed |
| Sumitomo Pharma America, INC. | $52.92 | 2023-2024 | Orgovyx |
| Pfizer INC. | $52.91 | 2020-2024 | |
| Alnylam Pharmaceuticals INC. | $49.85 | 2022-2023 | Oxlumo |
| Abbvie INC. | $42.42 | 2022-2024 | |
| Coloplast Corp | $34.90 | 2022-2025 | |
| Becton, Dickinson and Company | $29.29 | 2023 | Bard Urinary Drainage Bag |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endo USA, INC. | $28.11 | 2025 | Xiaflex, Aveed |
| Mission Pharmacal Company | $21.31 | 2022 | |
| Urogen Pharma, INC. | $21.09 | 2025 | |
| Calyxo, INC. | $20.77 | 2025 | Cvac Aspiration System |
| Travere Therapeutics, INC. | $17.77 | 2020-2021 | |
| Therapeuticsmd, INC. | $17.08 | 2019 | |
| Merck Sharp & Dohme LLC | $15.59 | 2023 | Lynparza, Welireg, Keytruda |
| Innovation Technologies INC | $13.80 | 2024 | Irrisept |
| Metuchen Pharmaceuticals | $13.49 | 2020 | |
| Ferring Pharmaceuticals INC. | $13.41 | 2019 | |
| Laborie Medical Technologies Corp. | $12.81 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Deena Theiss listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.